Marc Lehmann
Director Ejecutivo en SmartDyeLivery GmbH .
Cargos activos de Marc Lehmann
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
SmartDyeLivery GmbH
 SmartDyeLivery GmbH Medical/Nursing ServicesHealth Services SmartDyeLivery GmbH develops a technology for to transport active substances in certain cell types. The company was founded in 2016 by Ulrich S. Schubert und Michael Bauer and is headquartered in Jena, Denmark. | Director Ejecutivo | - | - |
Historial de carrera de Marc Lehmann
Antiguos cargos conocidos de Marc Lehmann.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
SIRS-Lab GmbH
 SIRS-Lab GmbH Medical SpecialtiesHealth Technology SIRS-Lab GmbH focuses on the development and commercialization of solutions for identification and detection of pathogens and antibiotic resistances. The company offers VYOO sepsis test that detects various bacterial and fungal species that cause sepsis, and LOOXSTER, which concentrates bacterial and fungal DNA contained in DNA-preparations, such as whole blood or ascites. It also provides gene expression services. SIRS-Lab was founded in 2000 by Stefan Russwurm, Eberhard Straube, Konrad Reinhart, and Hans Peter Saluz and is headquartered in Jena, Germany. | Corporate Officer/Principal | 25/11/2009 | 07/05/2013 |
Formación de Marc Lehmann.
| Friedrich Schiller University of Jena | Doctorate Degree |
Estadísticas
Internacional
| Alemania | 4 |
Operativa
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
| Chief Executive Officer | 1 |
Sectorial
| Consumer Services | 2 |
| Health Services | 2 |
| Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
SmartDyeLivery GmbH
SmartDyeLivery GmbH Medical/Nursing ServicesHealth Services SmartDyeLivery GmbH develops a technology for to transport active substances in certain cell types. The company was founded in 2016 by Ulrich S. Schubert und Michael Bauer and is headquartered in Jena, Denmark. | Health Services |
SIRS-Lab GmbH
SIRS-Lab GmbH Medical SpecialtiesHealth Technology SIRS-Lab GmbH focuses on the development and commercialization of solutions for identification and detection of pathogens and antibiotic resistances. The company offers VYOO sepsis test that detects various bacterial and fungal species that cause sepsis, and LOOXSTER, which concentrates bacterial and fungal DNA contained in DNA-preparations, such as whole blood or ascites. It also provides gene expression services. SIRS-Lab was founded in 2000 by Stefan Russwurm, Eberhard Straube, Konrad Reinhart, and Hans Peter Saluz and is headquartered in Jena, Germany. | Health Technology |
- Bolsa de valores
- Insiders
- Marc Lehmann
- Experiencia
